Dynavax Technologies Future Growth
Future criteria checks 4/6
Dynavax Technologies is forecast to grow earnings and revenue by 43.6% and 17.8% per annum respectively while EPS is expected to grow by 41.6% per annum.
Key information
43.6%
Earnings growth rate
41.6%
EPS growth rate
Biotechs earnings growth | 31.5% |
Revenue growth rate | 17.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 23 Feb 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 408 | 83 | 98 | 104 | 4 |
12/31/2025 | 347 | 52 | 65 | 80 | 4 |
12/31/2024 | 288 | 27 | 16 | 51 | 5 |
12/31/2023 | 232 | -6 | 96 | 101 | N/A |
9/30/2023 | 361 | 61 | 118 | 122 | N/A |
6/30/2023 | 459 | 111 | 147 | 152 | N/A |
3/31/2023 | 656 | 236 | 134 | 141 | N/A |
12/31/2022 | 723 | 293 | 56 | 63 | N/A |
9/30/2022 | 733 | 320 | 140 | 148 | N/A |
6/30/2022 | 674 | 228 | 142 | 153 | N/A |
3/31/2022 | 470 | 104 | 238 | 247 | N/A |
12/31/2021 | 439 | 72 | 326 | 336 | N/A |
9/30/2021 | 258 | -39 | 192 | 199 | N/A |
6/30/2021 | 163 | -6 | 101 | 105 | N/A |
3/31/2021 | 113 | -62 | -31 | -27 | N/A |
12/31/2020 | 40 | -75 | -103 | -92 | N/A |
9/30/2020 | 38 | -97 | -112 | -100 | N/A |
6/30/2020 | 35 | -138 | -115 | -94 | N/A |
3/31/2020 | 40 | -129 | -136 | -108 | N/A |
12/31/2019 | 35 | -156 | -151 | -121 | N/A |
9/30/2019 | 30 | -159 | -161 | -132 | N/A |
6/30/2019 | 21 | -163 | -166 | -144 | N/A |
3/31/2019 | 14 | -160 | -157 | -141 | N/A |
12/31/2018 | 8 | -159 | -146 | -131 | N/A |
9/30/2018 | 3 | -146 | -130 | -115 | N/A |
6/30/2018 | 1 | -128 | -110 | -99 | N/A |
3/31/2018 | 0 | -109 | -93 | -82 | N/A |
12/31/2017 | 0 | -95 | -78 | -78 | N/A |
9/30/2017 | 8 | -89 | N/A | -86 | N/A |
6/30/2017 | 8 | -102 | N/A | -97 | N/A |
3/31/2017 | 10 | -111 | N/A | -105 | N/A |
12/31/2016 | 11 | -112 | N/A | -107 | N/A |
9/30/2016 | 4 | -118 | N/A | -103 | N/A |
6/30/2016 | 5 | -113 | N/A | -97 | N/A |
3/31/2016 | 4 | -108 | N/A | -96 | N/A |
12/31/2015 | 4 | -107 | N/A | -93 | N/A |
9/30/2015 | 6 | -102 | N/A | -88 | N/A |
6/30/2015 | 7 | -102 | N/A | -88 | N/A |
3/31/2015 | 8 | -103 | N/A | -87 | N/A |
12/31/2014 | 11 | -91 | N/A | -74 | N/A |
9/30/2014 | 12 | -90 | N/A | -69 | N/A |
6/30/2014 | 12 | -76 | N/A | -58 | N/A |
3/31/2014 | 13 | -68 | N/A | -51 | N/A |
12/31/2013 | 11 | -75 | N/A | -59 | N/A |
9/30/2013 | 10 | -74 | N/A | -54 | N/A |
6/30/2013 | 10 | -76 | N/A | -55 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DYF1 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.7%).
Earnings vs Market: DYF1 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: DYF1 is expected to become profitable in the next 3 years.
Revenue vs Market: DYF1's revenue (17.8% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: DYF1's revenue (17.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DYF1's Return on Equity is forecast to be high in 3 years time